The Center for Alzheimer’s and Neurodegenerative Diseases was created in 2014 to find therapies to cure or halt the progression of dementia and related disorders. Alzheimer’s disease (AD) is the single largest health threat to our aging population, and demands a research effort commensurate with this problem.
Marc Diamond, M.D., Professor of Neurology and Neurotherapeutics, is the founding director of the Center, and has devoted his career to identifying mechanisms and new therapies for neurodegenerative diseases.
The Center is building a multidisciplinary team of independent scientists to study the question of protein amyloids. This includes new therapies, development of diagnostic tests to apply to human tissues, mouse models, cell models, biochemical and biophysical approaches, and structural biology.
The focus of the Center, coupled with the interdisciplinary approaches of its members, creates a unique opportunity to speed the development of effective treatment for neurodegenerative diseases.